Trials / Recruiting
RecruitingNCT06223841
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
A Clinical Trial of Phase Ib/II to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- SUNHO（China）BioPharmaceutical CO., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase Ib/II Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of IAP0971 in Patients with Advanced Malignant Tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IAP0971 | IAP0971 should be subcutaneous injected，q3w |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2026-03-01
- Completion
- 2027-03-01
- First posted
- 2024-01-25
- Last updated
- 2024-02-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06223841. Inclusion in this directory is not an endorsement.